Comparing interferon-γ release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents

Clinical Infectious Diseases

Volumn 40, Issue 2, 2005, Pages 246-250

  Tat, David ^a   Polenakovik, Hari ^a,b   Herchline, Thomas ^a,c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Weber Bldg WSU DOM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUBERCULIN;

ADULT; AGED; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; RELIABILITY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; FEMALE; HUMANS; INDICATORS AND REAGENTS; INTERFERON TYPE II; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 12144273606     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426816     Document Type: Article

References (39)

1. American Thoracic Society Medical Section of American Lung Association. Diagnostic standards and classification of tuberculosis. Am J Respir Crit Care Med 2000; 161:1376-95.
2. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49(RR-6):1-51.
3. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002; 34:365-70.
4. Caiaffa WT, Graham N, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995; 155:2111-7.
5. Gordin FM, Perez-Stable EJ, Reid M, et al. Stability of positive tuberculin tests: are boosted reactions valid? Am Rev Respir Dis 1991; 144:560-3.
6. Perez-Stable EJ, Flaherty D, Schecter G, Slutkin G, Hopewell PC. Conversion and reversion of tuberculin reactions in nursing home residents. Am Rev Respir Dis 1988; 137:801-4.
7. Bearman JE, Kleinman H, Glyer VV, La Croix OM. A study of variability in tuberculin test reading. Am Rev Respir Dis 1964; 90:913-9.
8. Duchin JS, Jereb A, Nolan CM, Smith P, Onorato IM. Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis 1997; 25:661-3.
9. Marsh BJ, San Vicente J, von Reyn CF. Utility of dual skin tests to evaluate tuberculin skin test reactors of 10 to 14 mm in healthcare workers. Infect Control Hosp Epidemiol 2003; 24:821-4.
10. Huebner RE, Schein MF, Bass JBJ. The tuberculin skin test. Clin Infect Dis 1993; 17:968-75.
11. Cornstock GW. False tuberculin test results. Chest 1975; 68:465-9.
12. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon-γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286:1740-7.
13. Chaparas SD, Vandiviere, HM, Melvin I, Koch G, Becker C. Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis 1985; 132:175-7.
14. Black GF, Dockrell HM, Crampin AC, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001; 184:322-9.
15. Johnson PDR, Stuart RL, Grayson ML, et al. Tuberculin - purified protein derivative -. MPT-64 -, and ESAT-6 - stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999; 6:934-7.
16. Cauthen GM, Snider DE, Onorato IM, Boosting of tuberculin sensitivity among Southeast Asian refugees. Am J Respir Crit Care Med 1994; 149:1597-600.
17. Floyd S, Ponnighaus JM, Bliss L, et al. Kinetics of delayed-type hypersensitivity to tuberculin induced by Bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis 2002; 186:807-14.
18. Moreno S, Blazquez R, Novoa A, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001; 161:1760-5.
19. Sokal JE. Measurement of delayed skin-test responses. N Engl J Med 1975; 293:501-2.
20. Chaisson RE, Keruly JC, Mcavinue S, Gallant JE, Moore RD. Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:455-9.
21. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma-interferon blood test to tuberculosis. Int J Tuberc Lung Dis 1998; 2:443-50.
22. Desem N, Jones SL. Development of a human interferon-γ enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 1998; 5:531-6.
23. Pottumarthy, S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: Potential to replace the Mantoux skin test. J Clin Microbiol 1999; 37:3229-32.
24. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170:65-9.
25. Bellete B, Coberly J, Barnes GL, et al. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002; 34:1449-56.
26. Franchi A, Amicosante M, Rovatti E, et al. Evaluation of a Western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers. J Occup Environ Med 2000; 42:64-8.
27. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 2003; 52 (RR-2):15-8.
28. Nadal D. Is the in vitro interferon-γ release assay an adequate replacement for the tuberculin skin test? Clin Infect Dis 2002; 34:1457-9.
29. Pottumarthy S, Wells VC, Morris AJ. A comparison of seven tests for serological diagnosis of tuberculosis. J Clin Microbiol 2000; 38:2227-31.
30. World Health Organization Tuberculosis Research Office. Tuberculin reaction size on five consecutive days. Bull WHO 1955; 12:189-96.
31. Slutin G, Perez-Stable EJ, Hopewell PC. Time course and boosting of tuberculin reactors in nursing home residents. Am Rev Respir Dis 1986; 134:1048-51.
32. Robertson JM, Burtt DS, Edmonds KL, Molina PL, Kiefe CI, Ellner JJ. Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Ann Intern Med 1996; 124:779-84.
33. Fleiss JL. The measurement of interrater agreement. In: Bradley RA, Hunter JS, Kendal DG, Watson GS, eds. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981:212-36.
34. World Health Organization. Global tuberculosis control. Available at: http://www.who.int/gtb/publications/globrep99. Accessed 23 April 2004.
35. Menzies R, Vissandjee B. Effect of bacilli Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145:621-5.
36. Grabau ]C, Hughes SE, Foster EA, Kearns CH, Klopf L. False-positive tuberculin skin tests in a state prison system. Int J Tuberc Lung Dis 2003; 7:93-7.
37. Shands JW, Boeff D, Fauerbach L, Gutekunst RR. Tuberculin testing in a tertiary hospital: product variability. Infect Control Hosp Epidemiol 1994; 15:758-60.
38. Blumberg HM, White N, Parrott P, Gordon W, Hunter M, Ray S. False-positive tuberculin skin test results among health care workers [letter]. JAMA 2000; 283:2793.
39. Villarino ME, Burman W, Wang YC, et al. Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA 1999; 281:169-71.